PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAE4. A total of 13 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $26,678,000 | +5.4% | 17,710,000 | 0.0% | 0.52% | -1.7% |
| Q3 2014 | $25,302,000 | -20.6% | 17,710,000 | 0.0% | 0.53% | -24.4% |
| Q2 2014 | $31,877,000 | +16.6% | 17,710,000 | 0.0% | 0.70% | +19.3% |
| Q1 2014 | $27,332,000 | +0.1% | 17,710,000 | 0.0% | 0.58% | +8.3% |
| Q4 2013 | $27,295,000 | +7.2% | 17,710,000 | 0.0% | 0.54% | -4.8% |
| Q3 2013 | $25,466,000 | +25.7% | 17,710,000 | +20.0% | 0.57% | +9.5% |
| Q2 2013 | $20,254,000 | – | 14,762,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 30,974,000 | $43,580,000 | 17.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 21,021,000 | $28,930,000 | 5.41% |
| WHITEBOX ADVISORS LLC | 34,269,000 | $46,957,000 | 2.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,762,000 | $20,254,000 | 0.52% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $33,985,000 | 0.34% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $6,881,000 | 0.20% |
| Castle Creek Arbitrage, LLC | 1,000,000 | $1,376,000 | 0.06% |
| AQR Capital Management | 8,125,000 | $11,086,000 | 0.04% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 16,050,000 | $22,056,000 | 0.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,724,000 | $20,234,000 | 0.02% |